Advancing the Treatment of Focal Seizures in the Intensive Care Setting: A Multidisciplinary Team Approach

Listen to this CME Outfitters Live and On Demand activity as expert faculty highlight the patient voice in this 90-minute, case based, panel discussion of causes of focal seizures in the ICU, treatment options, and best practice management in this patient population.

 

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Social Workers (NASW)
  4. Pharmacists (ACPE)
  5. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Thursday, May 3, 2018

Faculty

 

Joseph I. Sirven, MD
 Joseph I. Sirven, MD
 (Moderator)
Professor and Chairman
Department of Neurology
Mayo Clinic College of Medicine
Mayo Clinic Arizona
Phoenix, AZ

 

Claudia Calvillo, BSN, RN, CCRN Claudia Calvillo, BSN, RN, CCRN
Neurological Intensive Care Unit
The University of Chicago Medical Center
Chicago, IL

 

Christopher L. Kramer, MD Christopher L. Kramer, MD
Assistant Professor
Department of Neurology
Neurointensive Care Specialist
The University of Chicago Medical Center
Chicago, IL

 

Statement of Need

Seizures are a common occurrence in the intensive care setting with incidence estimates ranging from 3.3% to 34%.1,2 Encountering seizures in the intensive care unit (ICU) is frightening to patients and caregivers. Discharge orders that include new medication and possibly a new diagnosis—in addition to other orders or instructions can be daunting and confusing. Clinicians need strategies focused on the needs of the patients for optimal outcomes.

Seizures occurring in the ICU require timely treatment with antiepileptic drugs (AEDs) to prevent status epilepticus, which can lead to permanent cerebral injury. Early treatment of seizures is associated with better patient outcomes and increased survival. Therefore, clinicians who treat patients in the intensive care setting must be able to quickly identify and optimally manage seizures to improve outcomes in these patients.

This CME Outfitters Live and On Demand features expert faculty highlighting the patient voice in this 90-minute, case based, panel discussion of causes of focal seizures in the ICU, treatment options, and best practice management in this patient population.

References:
1. Bleck TP, Smith MC, Pierre-Louis SJ, Jares JJ, Murray J, Hansen CA. Neurologic complications of critical medical illnesses. Crit Care Med. 1993;21(1):98-103.
2. Jordan KG. Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J Clin Neurophysiol. 1999;16(1):14-39.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Describe the potential causes of focal seizures in patients in the intensive care setting and factors that complicate seizure management in this patient population.
  • Select appropriate treatments for patients with focal seizures in the intensive care setting based on seizure etiology, individual patient characteristics, and acute symptoms.
  • Develop appropriate treatment plans for continued long-term treatment of seizures at time of patient discharge.

The following learning objectives pertain only to those requesting CNE credit:

  • Describe the potential causes of focal seizures in patients in the intensive care setting and factors that complicate seizure management in this patient population.
  • Identify appropriate treatments for patients with focal seizures in the intensive care setting based on seizure etiology, individual patient characteristics, and acute symptoms.
  • Describe appropriate treatment plans for continued long-term treatment of seizures at time of patient discharge.

Financial Support

Supported by an educational grant from UCB, Inc.

Target Audience

Physicians, physician assistants, nurse practitioners, pharmacists, nurses, social workers, and other healthcare professionals with an interest in focal seizures in the ICU.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology.  Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTMthrough the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)TM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

NASW Credit (Social Workers):
This program is Approved by the National Association of Social Workers (Approval # 886407722-9359) for 1.5 continuing education contact hours.

CPE Credit (Pharmacists):
ACPECME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Live: 0376-0000-17-006-L01-P
Enduring: 0376-0000-17-006-H01-P

Type: Knowledge-based

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST21208 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Sirven has disclosed that he receives grant support from GW Pharmaceuticals. He serves as a consultant for NeuroPace, Inc. and UCB, Inc.

Ms. Calvillo has no disclosures to report.

Dr. Kramer has no disclosures to report.

Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.

Kimberley Murray, RN, MS (peer reviewer) has no disclosures to report.

Daniela V. DiBiase, MS (planning committee) has no disclosures to report.

Sharon Tordoff, CHCP (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS(877.263.7767).